Literature DB >> 8727047

Cytokine production by a megakaryocytic cell line.

B Sandrock1, K M Hudson, D E Williams, M A Lieberman.   

Abstract

The regulation of megakaryopoeisis by cytokines is not yet well understood. It is possible that autocrine loops are established during megakaryocyte growth and differentiation, aiding in the maturation of these cells. The CHRF-288-11 human megakaryoblastic cell line has been examined for cytokine production in growing cells and cells stimulated to differentiate by the addition of phorbol esters. It has been demonstrated that these cells produce RNA corresponding to the interleukins IL-1 alpha, 1 beta, 3, 7, 8, and 11, granulocyte-macrophage colony stimulating factor (GM-CSF), stem cell factor (SCF), transforming growth factor-beta (TGF-beta), tumor necrosis factor-alpha (TNF-alpha), interferon-alpha (INF-alpha), and basic fibroblast growth factor (bFGF). Additionally, RNA corresponding to the receptors for IL-6, GM-CSF, SCF, INF-alpha, beta, bFGF, and monocyte colony stimulating factor (M-CSF) were also expressed by the cells. The receptor for TNF-alpha was detected immunologically. Analysis at the protein level demonstrated that significant amounts of INF-alpha, TNF-alpha, GM-CSF, SCF, IL-1 alpha, and a soluble form of the IL-6 receptor were produced by the cells. Addition of phorbol esters to CHRF-288-11 cells enhances their megakaryocytic phenotype; such treatment also results in increased secretion of INF-alpha, TNF-alpha, and GM-CSF. These results suggest that potential autocrine loops are established during the differentiation of CHRF-288-11 cells, which may alter the capability of the cell to differentiate. These findings are similar to those recently obtained for marrow-derived megakaryocytes (Jiang et al.) suggesting that CHRF-288-11 cells provide a useful model system for the study of cytokine release during megakaryocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8727047     DOI: 10.1007/BF02722950

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  95 in total

Review 1.  Regulation of human megakaryocytopoiesis.

Authors:  Z C Han; S Bellucci; J P Caen
Journal:  Nouv Rev Fr Hematol       Date:  1990

2.  Hemin-induced erythroid differentiation changes the sensitivity of K562 cells to tumor necrosis factor-alpha.

Authors:  X F Li; J Anderson; D Hutzler; G D Roodman
Journal:  Exp Hematol       Date:  1989-12       Impact factor: 3.084

3.  Regulation of megakaryocyte phenotype in human erythroleukemia cells.

Authors:  M W Long; C H Heffner; J L Williams; C Peters; E V Prochownik
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.

Authors:  F J de Sauvage; P E Hass; S D Spencer; B E Malloy; A L Gurney; S A Spencer; W C Darbonne; W J Henzel; S C Wong; W J Kuang
Journal:  Nature       Date:  1994-06-16       Impact factor: 49.962

6.  Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.

Authors:  W Brugger; W Möcklin; S Heimfeld; R J Berenson; R Mertelsmann; L Kanz
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

7.  Cytokine gene expression and synthesis by human megakaryocytic cells.

Authors:  H Avraham; E Vannier; S Y Chi; C A Dinarello; J E Groopman
Journal:  Int J Cell Cloning       Date:  1992-03

8.  Comparative effects of in vivo treatment using interleukin-11 and stem cell factor on reconstitution in mice after bone marrow transplantation.

Authors:  X X Du; D Keller; R Maze; D A Williams
Journal:  Blood       Date:  1993-08-01       Impact factor: 22.113

9.  Functional and morphological differentiation induction of a human megakaryoblastic leukemia cell line (MEG-01s) by phorbol diesters.

Authors:  M Ogura; Y Morishima; M Okumura; T Hotta; S Takamoto; R Ohno; N Hirabayashi; H Nagura; H Saito
Journal:  Blood       Date:  1988-07       Impact factor: 22.113

10.  Transforming growth factor beta inhibits endomitosis in the Dami human megakaryocytic cell line.

Authors:  S M Greenberg; C Chandrasekhar; D E Golan; R I Handin
Journal:  Blood       Date:  1990-08-01       Impact factor: 22.113

View more
  4 in total

1.  Platelet expression of tumour necrosis factor-alpha (TNF-alpha), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy.

Authors:  G A Limb; L Webster; H Soomro; S Janikoun; J Shilling
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 2.  Megakaryocytes as immune cells.

Authors:  Pierre Cunin; Peter A Nigrovic
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

3.  Signal transduction of c-Kit receptor tyrosine kinase in CHRF myeloid leukemia cells.

Authors:  Sebastian Scholl; Cornelia Kirsch; Frank D Böhmer; Reinhard Klinger
Journal:  J Cancer Res Clin Oncol       Date:  2004-08-31       Impact factor: 4.553

4.  Large-scale generation of megakaryocytes from human embryonic stem cells using transgene-free and stepwise defined suspension culture conditions.

Authors:  Bowen Zhang; Xumin Wu; Guicheng Zi; Lijuan He; Sihan Wang; Lin Chen; Zeng Fan; Xue Nan; Jiafei Xi; Wen Yue; Lei Wang; Liu Wang; Jie Hao; Xuetao Pei; Yanhua Li
Journal:  Cell Prolif       Date:  2021-02-21       Impact factor: 6.831

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.